Brenner West Capital Advisors - ADAMAS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Brenner West Capital Advisors ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$20,249,000
-0.5%
1,011,431
+28.4%
2.52%
+10.5%
Q2 2018$20,347,000
-10.1%
787,723
-16.8%
2.28%
-26.3%
Q1 2018$22,633,000
-47.4%
947,006
-25.4%
3.09%
-45.1%
Q4 2017$43,044,000
+19.5%
1,270,123
-25.4%
5.64%
+31.0%
Q3 2017$36,020,000
+45.0%
1,701,477
+19.8%
4.30%
+48.9%
Q2 2017$24,839,000
+19.1%
1,420,156
+19.2%
2.89%
+37.4%
Q1 2017$20,847,000
+1.0%
1,191,282
-2.5%
2.10%
-7.7%
Q4 2016$20,643,000
+7.6%
1,221,463
+4.5%
2.28%
+32.9%
Q3 2016$19,188,000
+24.6%
1,169,275
+15.0%
1.72%
+28.0%
Q2 2016$15,397,000
+96.0%
1,017,000
+87.2%
1.34%
+116.8%
Q1 2016$7,855,000543,2380.62%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders